Menu
Not yet recruiting NCT06725849

Barriers to Physical Activity in Familial Mediterranean Fever

Observational Familial Mediterranean Fever (FMF )

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
This is an observational study: the protocol does not assign a study treatment.
Who it may be relevant to
Registry conditions: Familial Mediterranean Fever (FMF ). Basic parameters: 18 years — 65 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Turkey (Türkiye)
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Barriers to Physical Activity and Exercise in Patients With Familial Mediterranean Fever

Overview

This project is a 2209-A TÜBİTAK project. It has been developed to identify the barriers to physical activity among patients diagnosed with Familial Mediterranean Fever (FMF). The project aims to determine the problems encountered by FMF patients when engaging in physical activity and the reasons behind these issues, using various assessment methods to identify the reasons for avoiding physical activity.

Detailed description

This project is a 2209-A TÜBİTAK project. It has been developed to identify the barriers to physical activity among patients diagnosed with Familial Mediterranean Fever (FMF) referred to the Department of Internal Medicine, Rheumatology Division, at Istanbul University-Cerrahpaşa, Cerrahpaşa Medical Faculty, as well as the Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation.

The project aims to determine the problems encountered by FMF patients when engaging in physical activity and the reasons behind these issues, using various assessment methods to identify the reasons for avoiding physical activity. Patients diagnosed with FMF will be evaluated based on pain (McGill Melzack Pain Questionnaire), quality of life (FMF Quality of Life Measure), fatigue status (Fatigue Severity Scale), kinesiophobia (Tampa Scale for Kinesiophobia), grip strength (Digital Hydraulic Hand Dynamometer), and aerobic capacity (Spirometer).

Assessments will be conducted twice a week for three months, with each session lasting 30 minutes, utilizing the Digital Hydraulic Hand Dynamometer and Spirometer under the supervision of researchers.

Primary outcome measures

  • International Physical Activity Questionnaire Short [Time frame: It will be applied once for up to 6 months.]
  • Familial Mediterranean Fever Quality of Life Scale [Time frame: It will be applied once for up to 6 months.]
Secondary outcome measures (5)
  • McGill Melzack Pain Questionnaire [Time frame: It will be applied once for up to 6 months.]
  • Tampa Scale for Kinesiophobia-Fatigue [Time frame: It will be applied once for up to 6 months.]
  • Fatigue Severity Scale [Time frame: It will be applied once for up to 6 months.]
  • Digital Hydraulic Hand Dynamometer [Time frame: It will be applied once for up to 6 months.]
  • Aerobic Capacity Assessment: Spirometer [Time frame: It will be applied once for up to 6 months.]

Eligibility criteria

Inclusion criteria

  • Diagnosis of Familial Mediterranean Fever (FMF)
  • Ability to respond to the questionnaires
  • Capability to engage in physical activity

Exclusion criteria

  • Any form of disability (visual, auditory, mental, physical)
  • Illiteracy in Turkish
  • Presence of comorbidities that may hinder assessment

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Case-only

Study locations

Turkey (Türkiye) · 1 center
  • Istanbul University-Cerrahpasa — Istanbul

Identifiers

NCT: NCT06725849 · ISTANBULC6

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗